Home › NDC Lookup › RxCUI directory › RxCUI 240209

Betamethasone 0.5 MG/ML Topical Lotion — RxCUI 240209

RxNorm drug concept · Semantic clinical drug
RxCUI 240209 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI240209
Official nameBetamethasone 0.5 MG/ML Topical Lotion
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbetamethasone 0.05 % Topical Lotion; betamethasone dipropionate 0.05 % Topical Lotion; betamethasone 0.5 MG/ML (betamethasone dipropionate 0.64 MG/ML) Topical Lotion
FDA products mapped5
Package NDCs mapped7
Reported Medicaid activity (SDUD)45,957 prescriptions · 44 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Betamethasone Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Betamethasone topical is used for skin conditions that respond to steroid treatment — things like psoriasis, eczema, and other inflammatory skin problems that cause redness and itc...
  • What skin conditions does betamethasone topical treat?
  • Apply a small amount — a thin layer or just a few drops — directly to the affected area once or twice daily, depending on which product you have. Rub it in gently until it disappea...
  • These products are meant for short-term use. In general, you should see improvement within two weeks — if you don't, check back with your doctor rather than continuing on your own....
📖 Read our full Betamethasone Topical guide →

🕸️ Concept Web — How Betamethasone 0.5 MG/ML Topical Lotion Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Betamethasone 0.5 MG/ML Topical Lotion RxCUI 240209

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Betamethasone 1514
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Del-Beta 216427
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Betamethasone Topical Lotion 377614
    • Betamethasone Topical Product 1153804
    • Betamethasone Topical Lotion [Del-Beta] 365805
    • Del-Beta Topical Product 1171682
    • Topical Lotion 316983
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Betamethasone 0.5 MG/ML 340130
    • Betamethasone 0.5 MG/ML Topical Lotion [Del-Beta] 351894
    • Betamethasone 0.5 MG/ML [Del-Beta] 573427

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Betamethasone 0.5 MG/ML SCDC · 340130
  • Betamethasone Topical Lotion SCDF · 377614
  • Betamethasone Topical Product SCDG · 1153804

Brand-Name Concepts

  • Betamethasone 0.5 MG/ML Topical Lotion [Del-Beta] SBD · 351894
  • Betamethasone 0.5 MG/ML [Del-Beta] SBDC · 573427
  • Betamethasone Topical Lotion [Del-Beta] SBDF · 365805
  • Del-Beta Topical Product SBDG · 1171682
  • Del-Beta BN · 216427

📦 FDA Products & Package NDCs

5 products · 7 package NDCs
7 package NDCs map to RxCUI 240209 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00168-0055-15 1 TUBE in 1 CARTON (0168-0055-15) / 15 g in 1 TUBE Betamethasone Dipropionate E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 1984-06-26
00168-0055-46 1 TUBE in 1 CARTON (0168-0055-46) / 45 g in 1 TUBE Betamethasone Dipropionate E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 1984-06-26
00168-0056-15 1 TUBE in 1 CARTON (0168-0056-15) / 15 g in 1 TUBE Betamethasone Dipropionate E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 1984-09-04
00168-0056-46 1 TUBE in 1 CARTON (0168-0056-46) / 45 g in 1 TUBE Betamethasone Dipropionate E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 1984-09-04
00168-0057-60 1 BOTTLE in 1 CARTON (0168-0057-60) / 60 mL in 1 BOTTLE Betamethasone Dipropionate E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 1985-08-12
00713-0807-53 1 BOTTLE in 1 CARTON (0713-0807-53) / 60 mL in 1 BOTTLE Betamethasone Dipropionate Cosette Pharmaceuticals, Inc. 2016-09-05
45802-0021-46 56.2 g in 1 BOTTLE, PLASTIC (45802-021-46) Betamethasone Dipropionate Padagis Israel Pharmaceuticals Ltd 2006-06-30
Observed labelers: E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC (5) · Cosette Pharmaceuticals, Inc. (1) · Padagis Israel Pharmaceuticals Ltd (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.